- Report
- March 2024
- 121 Pages
Middle East, Africa
From €1433EUR$1,500USD£1,220GBP
- Report
- May 2022
- 95 Pages
Global
From €1529EUR$1,600USD£1,301GBP
- Report
- January 2022
- 133 Pages
Global
From €2628EUR$2,750USD£2,236GBP
€5256EUR$5,500USD£4,472GBP
- Report
- December 2020
- 193 Pages
Global
From €4730EUR$4,950USD£4,025GBP
- Report
- January 2022
- 200 Pages
Global
From €7167EUR$7,500USD£6,098GBP
- Report
- January 2022
- 200 Pages
Global
From €7167EUR$7,500USD£6,098GBP
- Report
- January 2022
- 60 Pages
Global
From €3775EUR$3,950USD£3,212GBP
- Report
- January 2022
- 60 Pages
Global
From €3775EUR$3,950USD£3,212GBP
- Report
- August 2023
- 78 Pages
Canada
From €3345EUR$3,500USD£2,846GBP
- Report
- June 2021
- 100 Pages
Global
From €4300EUR$4,500USD£3,659GBP
- Report
- September 2018
- 148 Pages
Global
From €3044EUR$3,185USD£2,590GBP
€4348EUR$4,550USD£3,700GBP
- Report
- February 2021
- 48 Pages
Global
€1260EUR$1,318USD£1,072GBP
- Report
- June 2018
- 41 Pages
Global
From €1260EUR$1,318USD£1,072GBP
- Report
- January 2023
- 175 Pages
Global
From €2389EUR$2,500USD£2,033GBP
- Report
- August 2022
United States
From €1854EUR$1,940USD£1,577GBP
- Report
- August 2022
Global
From €1042EUR$1,090USD£886GBP
- Report
- August 2021
Europe
From €3268EUR$3,420USD£2,781GBP
- Report
- August 2021
Global
From €3813EUR$3,990USD£3,244GBP
- Report
- February 2021
Global
From €2829EUR$2,960USD£2,407GBP
- Drug Pipelines
- September 2022
- 131 Pages
Global
From €10507EUR$10,995USD£8,940GBP
The Osteoarthritis Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. Osteoarthritis is a degenerative joint disease that affects millions of people worldwide. It is characterized by the breakdown of cartilage in the joints, leading to pain, stiffness, and decreased mobility. Treatment for osteoarthritis typically involves a combination of lifestyle changes, physical therapy, and medications. Common medications used to treat osteoarthritis include non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, and disease-modifying antirheumatic drugs (DMARDs).
The Osteoarthritis Drug market is highly competitive, with a variety of companies offering products to treat the condition. Some of the major players in the market include Pfizer, Merck, Novartis, AbbVie, and Johnson & Johnson. Other companies such as Amgen, Eli Lilly, and Bristol-Myers Squibb also offer products for the treatment of osteoarthritis. Show Less Read more